miR-29a inhibits human retinoblastoma progression by targeting STAT3

Shu Liu(Guangdong Province Women and Children Hospital), Chunling Xu(Alibaba Group (China))
Oncology Reports
December 11, 2017
Cited by 31


Related Papers